Duodenal diverted sleeve gastrectomy with ileal interposition does not cause XXXX .

@entity1 @entity353 @entity28 @entity6 @entity8884 @entity3147 @entity1125 @entity30361
BACKGROUND: Duodenal diverted sleeve gastrectomy with ileal interposition (DDSG-II) is a bariatric-metabolic operation designed to treat @entity6 ( @entity6 ). It is restrictive (SG) but also acts on the small bowel with functional effects. The objective of the present study was to investigate whether or not it is also a malabsorptive operation. METHODS: Twelve @entity28 @entity1 (9 female and 3 male) affected by @entity6 had DDSG-II. Follow-up was every 3 months, and the results after 1 year are reported here. Clinical conditions, related to @entity6 and @entity3147 , changes in weight, body mass index, fasting glucose plasma levels, HbA1c (glycated hemoglobin %), basal insulin, vitamin B12, folic acid, vitamin D, total proteins, albumin, and hemoglobin were recorded. Basal plasma levels of @entity30361 (pg/mL) and of 7a-hydroxy-4-cholesten-3-one (C4) ( g/dL) were also determined for the diagnosis of @entity1125 . The results were expressed as mean  SEM, and the differences between times compared by the Mann Whitney U test; P<.05 was considered significant. RESULTS: After 1 year, all @entity1 had a significant @entity353 (-33.2  3 kg) with @entity6 remission according to the American @entity6 Association criteria (11), criteria. No significant changes in total proteins, albumin, hemoglobin, and vitamins (B6, B12, and D) were detected. C4 did not change after the operation (2  .5   g/dL versus 1.6  .5   g/dL), whereas @entity30361 significantly increased (from 85  11.2 pg/mL to 166.4  28.2 pg/mL, P<.04). Only 2 @entity1 had mild symptoms of @entity8884 . CONCLUSIONS: DDSG-II is effective for treatment of @entity6 @entity1 , increases the enterokine @entity30361 , and does not cause @entity1125 .
